Top compounds associated with response to TENM3


Feature Type Standardized
Nominal ANOVA
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.036 0.3
mRNA neopeltolide CTRPv2 pan-cancer AAC 0.082 0.3
mRNA Bicalutamide GDSC1000 pan-cancer AAC -0.04 0.3
mRNA thapsigargin gCSI pan-cancer AAC 0.063 0.3
mRNA Compound 1541A CTRPv2 pan-cancer AAC -0.043 0.3
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC -0.035 0.3
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.037 0.3
mRNA Crizotinib gCSI pan-cancer AAC -0.063 0.3
mRNA PD-0332991 CCLE pan-cancer AAC -0.051 0.3
mRNA WZ4002 CTRPv2 pan-cancer AAC 0.047 0.3
Download CSV